Evidence map›Paper›PMID 34626333›Full record

ArticleNeuroinformatics2022

Convolutional Neural Network Based Frameworks for Fast Automatic Segmentation of Thalamic Nuclei from Native and Synthesized Contrast Structural MRI.

Lavanya Umapathy, Mahesh Bharath Keerthivasan, Natalie M Zahr, Ali Bilgin, Manojkumar Saranathan

Open access · greenAbstract read
In one paragraph

Article in Neuroinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A deep learning framework for comprehensive segmentation of deep grey nuclei.medRxiv : the preprint server for health sciences · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Lavanya UmapathyDepartment of Electrical and Computer Engineering, University of Arizona, Tucson, AZ, USA.
Mahesh Bharath KeerthivasanDepartment of Medical Imaging, University of Arizona, Tucson, AZ, 85724, USA.
Natalie M ZahrDepartment of Psychiatry & Behavioral Sciences, Stanford University, Menlo Park, CA, USA.
Ali BilginDepartment of Electrical and Computer Engineering, University of Arizona, Tucson, AZ, USA.
Manojkumar SaranathanDepartment of Electrical and Computer Engineering, University of Arizona, Tucson, AZ, USA. manojsar@radiology.arizona.edu.ORCID http://orcid.org/0000-0001-9020-9948
University of Arizona · USMedical Solutions · GBMenlo School · US

Funding

Substructural Volumetry of Hippocampus and Thalamus in AlcoholismR21AA023582 · NIAAA · SRI INTERNATIONAL · PI SARANATHAN, MANOJKUMAR, ZAHR, NATALIE M · 2015 to 2016
$502k
NIAAA NIH HHS R21 AA023582
6 · The paper itself

Abstract

Thalamic nuclei have been implicated in several neurological diseases. Thalamic nuclei parcellation from structural MRI is challenging due to poor intra-thalamic nuclear contrast while methods based on diffusion and functional MRI are affected by limited spatial resolution and image distortion. Existing multi-atlas based techniques are often computationally intensive and time-consuming. In this work, we propose a 3D convolutional neural network (CNN) based framework for thalamic nuclei parcellation using T1-weighted Magnetization Prepared Rapid Gradient Echo (MPRAGE) images. Transformation of images to an efficient representation has been proposed to improve the performance of subsequent classification tasks especially when working with limited labeled data. We investigate this by transforming the MPRAGE images to White-Matter-nulled MPRAGE (WMn-MPRAGE) contrast, previously shown to exhibit good intra-thalamic nuclear contrast, prior to the segmentation step. We trained two 3D segmentation frameworks using MPRAGE images (n = 35 subjects): (a) a native contrast segmentation (NCS) on MPRAGE images and (b) a synthesized contrast segmentation (SCS) where synthesized WMn-MPRAGE representation generated by a contrast synthesis CNN were used. Thalamic nuclei labels were generated using THOMAS, a multi-atlas segmentation technique proposed for WMn-MPRAGE images. The segmentation accuracy and clinical utility were evaluated on a healthy cohort (n = 12) and a cohort (n = 45) comprising of healthy subjects and patients with alcohol use disorder (AUD), respectively. Both the segmentation CNNs yielded comparable performances on most thalamic nuclei with Dice scores greater than 0.84 for larger nuclei and at least 0.7 for smaller nuclei. However, for some nuclei, the SCS CNN yielded significant improvements in Dice scores (medial geniculate nucleus, P = 0.003, centromedian nucleus, P = 0.01) and percent volume difference (ventral anterior, P = 0.001, ventral posterior lateral, P = 0.01) over NCS. In the AUD cohort, the SCS CNN demonstrated a significant atrophy in ventral lateral posterior nucleus in AUD patients compared to healthy age-matched controls (P = 0.01), agreeing with previous studies on thalamic atrophy in alcoholism, whereas the NCS CNN showed spurious atrophy of the ventral posterior lateral nucleus. CNN-based segmentation of thalamic nuclei provides a fast and automated technique for thalamic nuclei prediction in MPRAGE images. The transformation of images to an efficient representation, such as WMn-MPRAGE, can provide further improvements in segmentation performance.

Indexed as

Magnetic Resonance ImagingWhite MatterAtrophyHumansImage Processing, Computer-AssistedNeural Networks, ComputerThalamic Nuclei3D convolutional neural networksAlcohol use disorderContrast synthesisRepresentational learningThalamic-nuclei segmentationWhite-matter-nulled MPRAGE

Identifiers

PMID34626333
PMCPMC8993941
OpenAlexW3204577561

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.